I noticed Amgen is really changing fast, trying to do better. However the stock market is doing very poorly. Is that why Amgen's support level is around 56, or is it just investors being cautious about this stock?
Just to clarify any misconceptions that your post may generate, it is irrelevant as to when they report-21st or 29th, thwe cutoff for revenue recognition is June 30. Any sales recorded in July will be Q3 revenues.
However, moving the reporting date to the 29th will give them a greater insight as to the sales rampup up that is currently taking place with Prolia and this will give them the confidence to may be revise their numbers one way or another.
After July 29 Earning report...the manipulators and accumulators will be on the other side..pumping or talking highly of this stock. AMGN will guide upward, surprise in current Q earnings with early launch of prolia..and BLA filing for Cancer indications...